KYTX
Price
$3.39
Change
+$0.45 (+15.31%)
Updated
Jun 6 closing price
Capitalization
146.51M
72 days until earnings call
OPT
Price
$3.41
Change
+$0.23 (+7.23%)
Updated
Mar 17 closing price
Capitalization
479.46M
82 days until earnings call
Interact to see
Advertisement

KYTX vs OPT

Header iconKYTX vs OPT Comparison
Open Charts KYTX vs OPTBanner chart's image
Kyverna Therapeutics
Price$3.39
Change+$0.45 (+15.31%)
Volume$528.73K
Capitalization146.51M
Opthea
Price$3.41
Change+$0.23 (+7.23%)
Volume$3.03K
Capitalization479.46M
KYTX vs OPT Comparison Chart
Loading...
KYTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYTX vs. OPT commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYTX is a Buy and OPT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (KYTX: $3.39 vs. OPT: $3.41)
Brand notoriety: KYTX and OPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYTX: 167% vs. OPT: 100%
Market capitalization -- KYTX: $146.51M vs. OPT: $479.46M
KYTX [@Biotechnology] is valued at $146.51M. OPT’s [@Biotechnology] market capitalization is $479.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYTX’s FA Score shows that 0 FA rating(s) are green whileOPT’s FA Score has 0 green FA rating(s).

  • KYTX’s FA Score: 0 green, 5 red.
  • OPT’s FA Score: 0 green, 5 red.
According to our system of comparison, KYTX is a better buy in the long-term than OPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYTX’s TA Score shows that 4 TA indicator(s) are bullish.

  • KYTX’s TA Score: 4 bullish, 3 bearish.

Price Growth

KYTX (@Biotechnology) experienced а +32.94% price change this week, while OPT (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

KYTX is expected to report earnings on Aug 18, 2025.

OPT is expected to report earnings on Aug 28, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OPT($479M) has a higher market cap than KYTX($147M). KYTX YTD gains are higher at: -9.358 vs. OPT (-13.176). KYTX has higher annual earnings (EBITDA): -108.46M vs. OPT (-218.88M). KYTX has more cash in the bank: 322M vs. OPT (132M). KYTX has less debt than OPT: KYTX (9.14M) vs OPT (157M). OPT has higher revenues than KYTX: OPT (87.7K) vs KYTX (0).
KYTXOPTKYTX / OPT
Capitalization147M479M31%
EBITDA-108.46M-218.88M50%
Gain YTD-9.358-13.17671%
P/E RatioN/AN/A-
Revenue087.7K-
Total Cash322M132M244%
Total Debt9.14M157M6%
FUNDAMENTALS RATINGS
OPT: Fundamental Ratings
OPT
OUTLOOK RATING
1..100
49
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KYTX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
75%
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
70%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Declines
ODDS (%)
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Interact to see
Advertisement
KYTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DHSYX23.110.37
+1.63%
Diamond Hill Small Cap Y
LGOFX28.81N/A
N/A
Lord Abbett Growth Opportunities F
FCTGX27.85N/A
N/A
Fidelity Advisor Small Cap Growth M
EMCCX54.29N/A
N/A
Empiric Class C
BVALX14.29N/A
N/A
Brown Advisory BeutelGoodmanLg-CpValInst

KYTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYTX has been loosely correlated with IMNM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if KYTX jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYTX
1D Price
Change %
KYTX100%
+15.31%
IMNM - KYTX
47%
Loosely correlated
+0.11%
CABA - KYTX
47%
Loosely correlated
+13.76%
CRSP - KYTX
45%
Loosely correlated
+8.53%
IPSC - KYTX
45%
Loosely correlated
+9.47%
TRDA - KYTX
44%
Loosely correlated
+2.46%
More

OPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, OPT has been loosely correlated with PSTV. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if OPT jumps, then PSTV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OPT
1D Price
Change %
OPT100%
N/A
PSTV - OPT
35%
Loosely correlated
+2.04%
TNYA - OPT
35%
Loosely correlated
+17.37%
CYTK - OPT
27%
Poorly correlated
+0.69%
KYTX - OPT
26%
Poorly correlated
+15.31%
QLGN - OPT
25%
Poorly correlated
-1.57%
More